164 related articles for article (PubMed ID: 9876096)
1. Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column.
Tani T; Hanasawa K; Endo Y; Yoshioka T; Kodama M; Kaneko M; Uchiyama Y; Akizawa T; Takahasi K; Sugai K
Artif Organs; 1998 Dec; 22(12):1038-44. PubMed ID: 9876096
[TBL] [Abstract][Full Text] [Related]
2. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
Kodama M; Tani T; Maekawa K; Hirasawa H; Otsuka T; Takahashi Y; Kaneko M
Nihon Geka Gakkai Zasshi; 1995 May; 96(5):277-85. PubMed ID: 7596338
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.
Shoji H; Tani T; Hanasawa K; Kodama M
Ther Apher; 1998 Feb; 2(1):3-12. PubMed ID: 10227782
[TBL] [Abstract][Full Text] [Related]
5. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.
Mitaka C; Fujiwara N; Yamamoto M; Toyofuku T; Haraguchi G; Tomita M
J Crit Care; 2014 Oct; 29(5):728-32. PubMed ID: 24798345
[TBL] [Abstract][Full Text] [Related]
6. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
[TBL] [Abstract][Full Text] [Related]
7. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
Aoki H; Kodama M; Tani T; Hanasawa K
Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
[TBL] [Abstract][Full Text] [Related]
8. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.
Cruz DN; Perazella MA; Bellomo R; de Cal M; Polanco N; Corradi V; Lentini P; Nalesso F; Ueno T; Ranieri VM; Ronco C
Crit Care; 2007; 11(2):R47. PubMed ID: 17448226
[TBL] [Abstract][Full Text] [Related]
10. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
Mitaka C; Tomita M
Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
[TBL] [Abstract][Full Text] [Related]
11. Selective Polymyxin Hemoperfusion in Complex Therapy of Sepsis in Children after Cardiac Surgery.
Yaroustovsky M; Abramyan M; Rogalskaya E; Komardina E
Blood Purif; 2021; 50(2):222-229. PubMed ID: 33242859
[TBL] [Abstract][Full Text] [Related]
12. Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature.
Cruz DN; de Cal M; Piccinni P; Ronco C
Contrib Nephrol; 2010; 167():77-82. PubMed ID: 20519901
[TBL] [Abstract][Full Text] [Related]
13. Clinical effects of polymyxin B-immobilized fiber column in septic patients.
Cruz DN; Bellomo R; Ronco C
Contrib Nephrol; 2007; 156():444-51. PubMed ID: 17464156
[TBL] [Abstract][Full Text] [Related]
14. Endotoxin apheresis for sepsis.
Shimizu T; Endo Y; Tsuchihashi H; Akabori H; Yamamoto H; Tani T
Transfus Apher Sci; 2006 Dec; 35(3):271-82. PubMed ID: 17118710
[TBL] [Abstract][Full Text] [Related]
15. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
[TBL] [Abstract][Full Text] [Related]
16. Mortality Effects of Prolonged Hemoperfusion Therapy Using a Polymyxin B-Immobilized Fiber Column for Patients with Septic Shock: A Sub-Analysis of the DESIRE Trial.
Kawazoe Y; Sato T; Miyagawa N; Yokokawa Y; Kushimoto S; Miyamoto K; Ohta Y; Morimoto T; Yamamura H
Blood Purif; 2018; 46(4):309-314. PubMed ID: 30099437
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin removal column containing polymyxin B immobilized fiber is useful for the treatment of the patient with Vibrio vulnificus septicemia.
Sato T; Tadakuma N; Ikezaki N; Hashiguchi A; Masuda K
Artif Organs; 1998 Aug; 22(8):705-7. PubMed ID: 9702324
[TBL] [Abstract][Full Text] [Related]
18. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
[TBL] [Abstract][Full Text] [Related]
19. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
[TBL] [Abstract][Full Text] [Related]
20. Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock.
Nakamura T; Suzuki Y; Shimada N; Ebihara I; Shoji H; Koide H
Blood Purif; 1998; 16(4):179-86. PubMed ID: 9736787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
